Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome

por Lacy, Brian E
Publicado 2016

Review article: an analysis of safety profiles of treatments for diarrhoea‐predominant irritable bowel syndrome

por Lacy, Brian E.
Publicado 2018

Gastroparesis: Myths, Misconceptions, and Management

por Cangemi, David J, Lacy, Brian E
Publicado 2023

Lubiprostone: a novel treatment for chronic constipation

por Lacy, Brian E, Levy, L Campbell
Publicado 2008

Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome

por Lacy, Brian E., Patel, Nihal K.
Publicado 2017

Management of irritable bowel syndrome with diarrhea: a review of nonpharmacological and pharmacological interventions

por Cangemi, David J., Lacy, Brian E.
Publicado 2019

Antispasmodics for Chronic Abdominal Pain: Analysis of North American Treatment Options

por Brenner, Darren M., Lacy, Brian E.
Publicado 2021

Medication Risk-Taking Behavior in Functional Dyspepsia Patients

por Lacy, Brian E, Yu, Jerry, Crowell, Michael D
Publicado 2015

Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint

por Lacy, Brian E., Nicandro, Jean Paul, Chuang, Emil, Earnest, David L.
Publicado 2018

Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea

por Cash, Brooks D, Lacy, Brian E, Schoenfeld, Philip S, Dove, Leonard S, Covington, Paul S
Publicado 2017

Post-marketing reports of pancreatitis in eluxadoline-treated patients pre and post US label change

por Cash, Brooks D., Lacy, Brian E., Watton, Cheryl, Schoenfeld, Philip S., Weissman, Darren
Publicado 2021

Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials

por Shah, Eric D., Lacy, Brian E., Chey, William D., Chang, Lin, Brenner, Darren M.
Publicado 2021

Efficacy and safety of vibegron for the treatment of irritable bowel syndrome in women: Results of a randomized, double‐blind, placebo‐controlled phase 2 trial

por Lacy, Brian E., King, Jennifer, Shortino, Denise, Schaumburg, Chris, Haag‐Molkenteller, Cornelia, Chey, William D.
Publicado 2022

The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum

por Hussain, Zilla H, Henderson, Emily E, Maradey-Romerao, Carla, George, Nina, Fass, Ronnie, Lacy, Brian E
Publicado 2015

The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum

por Hussain, Zilla H, Henderson, Emily E, Maradey-Romerao, Carla, George, Nina, Fass, Ronnie, Lacy, Brian E
Publicado 2015

Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use

por Lacy, Brian E, Chey, William D, Cash, Brooks D, Lembo, Anthony J, Dove, Leonard S, Covington, Paul S
Publicado 2017

Fr014 DISEASE BURDEN AND CARE-SEEKING BEHAVIOR FOR IBS-C PATIENTS IN THE UNITED STATES IN THE ERA OF COVID-19

por Lacy, Brian E., Parekh, Mousam, Taylor, Douglas C., Rooker, Ceciel, Burslem, Kate, Morlock, Robert, Morlock, Amy
Publicado 2021

A Novel, Duodenal-Release Formulation of a Combination of Caraway Oil and L-Menthol for the Treatment of Functional Dyspepsia: A Randomized Controlled Trial

por Chey, William D., Lacy, Brian E., Cash, Brooks D., Epstein, Michael, Corsino, Patrick E., Shah, Syed M.
Publicado 2019

Lessons learned: Chronic idiopathic constipation patient experiences with over-the-counter medications

por Lacy, Brian E., Shea, Elizabeth P., Manuel, Machelle, Abel, Jessica L., Jiang, Hancheng, Taylor, Douglas C. A.
Publicado 2021

Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials

por Lacy, Brian E., Harris, Lucinda A., Chang, Lin, Lucak, Susan, Gutman, Catherine, Dove, Leonard S., Covington, Paul S., Lembo, Anthony
Publicado 2019